- Home
- AXSM vs TPH Comparison
AXSM vs TPH Comparison
Compare AXSM & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- TPH
- Stock Information
- Founded
- AXSM 2012
- TPH 2009
- Country
- AXSM United States
- TPH United States
- Employees
- AXSM N/A
- TPH N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- TPH Homebuilding
- Sector
- AXSM Health Care
- TPH Consumer Discretionary
- Exchange
- AXSM Nasdaq
- TPH Nasdaq
- Market Cap
- AXSM 5.1B
- TPH 2.8B
- IPO Year
- AXSM 2015
- TPH N/A
- Fundamental
- Price
- AXSM $110.12
- TPH $32.88
- Analyst Decision
- AXSM Strong Buy
- TPH Strong Buy
- Analyst Count
- AXSM 17
- TPH 5
- Target Price
- AXSM $171.65
- TPH $42.80
- AVG Volume (30 Days)
- AXSM 672.7K
- TPH 997.0K
- Earning Date
- AXSM 08-04-2025
- TPH 07-24-2025
- Dividend Yield
- AXSM N/A
- TPH N/A
- EPS Growth
- AXSM N/A
- TPH 20.35
- EPS
- AXSM N/A
- TPH 4.51
- Revenue
- AXSM $432,157,000.00
- TPH $4,294,395,999.00
- Revenue This Year
- AXSM $62.57
- TPH N/A
- Revenue Next Year
- AXSM $59.96
- TPH $7.76
- P/E Ratio
- AXSM N/A
- TPH $7.28
- Revenue Growth
- AXSM 72.16
- TPH 10.82
- 52 Week Low
- AXSM $72.21
- TPH $27.90
- 52 Week High
- AXSM $139.13
- TPH $47.78
- Technical
- Relative Strength Index (RSI)
- AXSM 56.52
- TPH 62.95
- Support Level
- AXSM $108.48
- TPH $33.48
- Resistance Level
- AXSM $114.66
- TPH $35.06
- Average True Range (ATR)
- AXSM 3.47
- TPH 0.98
- MACD
- AXSM 0.87
- TPH 0.17
- Stochastic Oscillator
- AXSM 64.95
- TPH 75.12
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.